Home › Funds › Alyeska Investment Group, L.P. › MDLN

Alyeska Investment Group, L.P. position in MDLN

MEDLINE INC · Health Care

Alyeska Investment Group, L.P. reported holding 6,809,122 shares of MDLN (MEDLINE INC) in its Q2 2026 13F filing — a position valued at US$268.6M, representing 0.69% of its reported portfolio and ranking #21 among its reported holdings. Alyeska Investment Group, L.P. has disclosed MDLN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)6.81M sh
Reported value held$268.55M
Portfolio Weight0.69%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alyeska Investment Group, L.P.'s MDLN position evolved

Alyeska Investment Group, L.P. first disclosed a stake in MDLN in Q4 2025 at 1,200,000 shares (US$50.4M). The position peaked in Q2 2026 at 6,809,122 shares, worth US$268.6M. Across 3 filings, Alyeska Investment Group, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,809,122 shares valued at US$268.6M — an increase of 3,871,733 shares quarter over quarter.. Notable position changes include a 145% increase in Q1 2026 (shares fell 11% over the following quarter), a 132% increase in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.20M $50.40M New
Q1 2026 2.94M $130.71M Add
Q2 2026 6.81M $268.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDLN and 13F data

MDLN (MEDLINE INC) is a Health Care company. 116 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$7.38B), Blackstone Inc. (US$4.01B), H&F Corporate Investors X, Ltd. (US$2.80B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDLN

All MDLN fund holders →

FAQ

How long has Alyeska Investment Group, L.P. held MDLN?

Alyeska Investment Group, L.P. has disclosed MDLN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Alyeska Investment Group, L.P.'s current position in MDLN?

As of Q2 2026, Alyeska Investment Group, L.P. holds 6.81M shares of MDLN (MEDLINE INC), valued at $268.55M, representing 0.69% of its reported portfolio and ranking #21.

Has Alyeska Investment Group, L.P. been buying or selling MDLN?

In the latest 13F filing (Q2 2026), Alyeska Investment Group, L.P. increased its position in MDLN. The position peaked in Q2 2026 at 6.81M shares.

Which other funds hold MDLN?

Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., H&F Corporate Investors X, Ltd., among 116 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.